Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the efficacy and safety of once-daily azilsartan medoxomil co-administered with amlodipine in adults with essential hypertension; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Azilsartan medoxomil (azilsartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19